Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 19, 2022
Should prostate cancer screening be different for black men?
New study confirms prostate cancer is more common and more deadly in African-Americans
Beyond Ben Stiller’s advice: What the experts say about PSA screening
The actor said a ‘prostate cancer test saved my life’; experts weigh in on when (and if) men should be screened
Good News at Fred Hutch
Celebrating faculty and staff achievements
Prostate cancer screening and rate of early diagnosis drops, studies find
An expert weighs in on whether new findings are good news, bad news or no news
Fred Hutch at ASCO
Research highlights from the annual meeting of the American Society of Clinical Oncology
The paradox of PSA screening for prostate cancer
New study forecasts population impact of discontinued testing
Intermittent hormone therapy for prostate cancer inferior to continuous therapy
Cathy Tangen contributes to international study, finding on again-off again prostate cancer treatment has quality of life benefits, but continuous therapy improves overall survival
Change in PSA level may not predict prostate cancer
Center statistical analyses show screening for PSA velocity can lead to unnecessary biopsies
ACS updates prostate cancer screening guidelines
Recommendations confirm the importance of shared decision making